 | Up a level |
Rizzo, Manfredi, Colletti, Alessandro, Penson, Peter E 
ORCID: 0000-0001-6763-1489, Katsiki, Niki, Mikhailidis, Dimitri P, Toth, Peter P, Gouni-Berthold, Ioanna, Mancini, John, Marais, David, Moriarty, Patrick et al (show 5 more authors)
(2023)
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).
PHARMACOLOGICAL RESEARCH, 189.
106679-.
Banach, Maciej, Surma, Stanislaw, Reiner, Zeljko, Katsiki, Niki, Penson, Peter E ORCID: 0000-0001-6763-1489, Fras, Zlatko, Sahebkar, Amirhossein, Paneni, Francesco, Rizzo, Manfredi and Kastelein, John
(2022)
Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022).
CARDIOVASCULAR DIABETOLOGY, 21 (1).
263-.
Banach, Maciej, Katsiki, Niki, Latkovskis, Gustavs, Rizzo, Manfredi, Pella, Daniel, Penson, Peter E ORCID: 0000-0001-6763-1489, Reiner, Zeljko and Cicero, Arrigo FG
(2021)
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.
ARCHIVES OF MEDICAL SCIENCE, 17 (4).
pp. 856-863.
Banach, Maciej, Catapano, Alberico L, Cicero, Arrigo FG, Escobar, Carlos, Foger, Bernhard, Katsiki, Niki, Latkovskis, Gustavs, Rakowski, Michal, Reiner, Zeljko, Sahebkar, Amirhossein et al (show 2 more authors)
(2022)
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel.
PHARMACOLOGICAL RESEARCH, 183.
106370-.